On April 12, 2024, Clover Biopharmaceuticals, Ltd closed the transaction. The transaction included participation from 10 investors, which includes a single non-accredited investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 HKD | +5.62% | +11.90% | -24.19% |
04-12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
04-08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.19% | 73.9M | |
+7.24% | 113B | |
+11.02% | 106B | |
+0.38% | 22.27B | |
-12.23% | 22.22B | |
-5.71% | 19.43B | |
-37.85% | 17.87B | |
-5.85% | 17.24B | |
+6.78% | 14.29B | |
+34.96% | 12.52B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding